{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T23:24:24Z","timestamp":1794525864378,"version":"4.9.1"},"reference-count":67,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,22]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Activation of the transcription factor forkhead box O1 (FOXO1) contributes to multiple pathological processes. The FOXO1 inhibitor AS1842856 demonstrated strong therapeutic effects in preclinical models of common diseases such as diabetes and anthracycline-induced heart failure. We have previously identified FOXO1 as a B-cell acute lymphoblastic leukemia (B-ALL) dependency and demonstrated in in vivo B-ALL models that AS1842856 increased the survival of animals and decreased B-ALL tumor load in all critical organ compartments, but most efficiently in the central nervous system. Here, we interrogated the underlying molecular mechanisms by comparison of the transcriptomic effects of AS1842856 and Foxo1 knockout (Foxo1-KO) in a B-ALL mouse model. Despite the significant similarity in sets of regulated genes, we identified glycogen synthase kinase (GSK) 3B inhibition as a signature enriched only in AS1842856-treated cells. Using an in vitro kinase assay and an unbiased kinome screen, we identified AS1842856 as a direct GSK3 inhibitor that ultimately stabilizes CTNNB1. CTNNB1-KO partially protected B-ALL cell lines from the cytotoxic effect of AS1842856. At the same time, using a chemical protein degradation model, we found that FOXO1 indeed contributes to the cytotoxic effect of AS1842856. We conclude that AS1842856 targets 2 B-lymphoid vulnerabilities: GSK3 and FOXO1. The unique mode of action, low toxicity, and ability to penetrate the blood-brain barrier warrant further investigation of the therapeutic potential of AS1842856 in B-ALL.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024015560","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T15:32:06Z","timestamp":1752075126000},"page":"3441-3454","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["Beyond FOXO1: AS1842856 inhibits GSK3 to enhance cytotoxic effects in B-ALL"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8525-5015","authenticated-orcid":false,"given":"Franz","family":"Ketzer","sequence":"first","affiliation":[{"name":"1Institute of Clinical Chemistry and Pathobiochemistry, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"B\u00fcttner","sequence":"additional","affiliation":[{"name":"2Institute of Physiological Chemistry, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4169-9273","authenticated-orcid":false,"given":"Daniel","family":"Geist","sequence":"additional","affiliation":[{"name":"2Institute of Physiological Chemistry, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3008-108X","authenticated-orcid":false,"given":"Anita","family":"Kick","sequence":"additional","affiliation":[{"name":"2Institute of Physiological Chemistry, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4539-9054","authenticated-orcid":false,"given":"Thomas","family":"Wirth","sequence":"additional","affiliation":[{"name":"2Institute of Physiological Chemistry, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3724-7253","authenticated-orcid":false,"given":"Alexey","family":"Ushmorov","sequence":"additional","affiliation":[{"name":"2Institute of Physiological Chemistry, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"24","key":"2025081210213591100_bib1","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1111\/febs.16221","article-title":"FOXOs: masters of the equilibrium","volume":"289","author":"Gui","year":"2022","journal-title":"FEBS J"},{"issue":"6","key":"2025081210213591100_bib2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ni.1612","article-title":"Foxo1 directly regulates the transcription of recombination-activating genes during B cell development","volume":"9","author":"Amin","year":"2008","journal-title":"Nat Immunol"},{"issue":"12","key":"2025081210213591100_bib3","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/ni.1667","article-title":"Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation","volume":"9","author":"Dengler","year":"2008","journal-title":"Nat Immunol"},{"issue":"6939","key":"2025081210213591100_bib4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature01667","article-title":"Insulin-regulated hepatic gluconeogenesis through FOXO1\u2013PGC-1\u03b1 interaction","volume":"423","author":"Puigserver","year":"2003","journal-title":"Nature"},{"issue":"11","key":"2025081210213591100_bib5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrd.2016.151","article-title":"Targeting hepatic glucose metabolism in the treatment of type 2 diabetes","volume":"15","author":"Rines","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"2025081210213591100_bib6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1124\/mol.110.065714","article-title":"Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db\/db mice","volume":"78","author":"Nagashima","year":"2010","journal-title":"Mol Pharmacol"},{"issue":"26","key":"2025081210213591100_bib7","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1182\/blood-2017-10-813576","article-title":"Tight regulation of FOXO1 is essential for maintenance of B-cell precursor acute lymphoblastic leukemia","volume":"131","author":"Wang","year":"2018","journal-title":"Blood"},{"issue":"15","key":"2025081210213591100_bib8","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood-2011-09-381905","article-title":"FOXO1 is a tumor suppressor in classical Hodgkin lymphoma","volume":"119","author":"Xie","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2025081210213591100_bib9","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/leu.2016.9","article-title":"Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K\/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition","volume":"30","author":"K\u00f6hrer","year":"2016","journal-title":"Leukemia"},{"issue":"6","key":"2025081210213591100_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood-2015-06-654111","article-title":"FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas","volume":"127","author":"Szydlowski","year":"2016","journal-title":"Blood"},{"issue":"10","key":"2025081210213591100_bib11","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/cancers11101427","article-title":"FOXO1 confers maintenance of the dark zone proliferation and survival program and can be pharmacologically targeted in Burkitt lymphoma","volume":"11","author":"Gehringer","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2025081210213591100_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41389-021-00377-0","article-title":"CCND3 is indispensable for the maintenance of B-cell acute lymphoblastic leukemia","volume":"11","author":"Ketzer","year":"2022","journal-title":"Oncogenesis"},{"issue":"2","key":"2025081210213591100_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/crispr.2019.0064","article-title":"A tandem guide RNA-based strategy for efficient CRISPR gene editing of cell populations with low heterogeneity of edited alleles","volume":"3","author":"Joberty","year":"2020","journal-title":"Crispr j"},{"issue":"1","key":"2025081210213591100_bib14","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1038\/s41467-020-18377-w","article-title":"Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules","volume":"11","author":"Nabet","year":"2020","journal-title":"Nat Commun"},{"issue":"1-2","key":"2025081210213591100_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ijch.201800113","article-title":"A chemical biology view of bioactive small molecules and a binder-based approach to connect biology to precision medicines","volume":"59","author":"Schreiber","year":"2019","journal-title":"Isr J Chem"},{"issue":"1","key":"2025081210213591100_bib16","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1038\/s41467-020-16927-w","article-title":"Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"11","author":"Abdelrasoul","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"2025081210213591100_bib17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.devcel.2010.03.008","article-title":"FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor","volume":"18","author":"Chen","year":"2010","journal-title":"Dev Cell"},{"issue":"2","key":"2025081210213591100_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.celrep.2016.03.021","article-title":"Integrated regulation of hepatic lipid and glucose metabolism by adipose triacylglycerol lipase and FoxO proteins","volume":"15","author":"Zhang","year":"2016","journal-title":"Cell Rep"},{"issue":"7818","key":"2025081210213591100_bib19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41586-020-2513-4","article-title":"Signalling input from divergent pathways subverts B cell transformation","volume":"583","author":"Chan","year":"2020","journal-title":"Nature"},{"key":"2025081210213591100_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semcancer.2017.07.008","article-title":"FOXO in B-cell lymphopoiesis and B cell neoplasia","volume":"50","author":"Ushmorov","year":"2018","journal-title":"Semin Cancer Biol"},{"issue":"W1","key":"2025081210213591100_bib21","doi-asserted-by":"crossref","first-page":"W212","DOI":"10.1093\/nar\/gkz446","article-title":"ChEA3: transcription factor enrichment analysis by orthogonal omics integration","volume":"47","author":"Keenan","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2025081210213591100_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cell.2016.02.064","article-title":"Suppression of enhancer overactivation by a RACK7-histone demethylase complex","volume":"165","author":"Shen","year":"2016","journal-title":"Cell"},{"issue":"43","key":"2025081210213591100_bib23","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1038\/s41388-021-02012-z","article-title":"Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia","volume":"40","author":"Heltemes-Harris","year":"2021","journal-title":"Oncogene"},{"issue":"2","key":"2025081210213591100_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.immuni.2013.07.013","article-title":"The transcription factor Foxo1 controls central-memory CD8+ T cell responses to infection","volume":"39","author":"Kim","year":"2013","journal-title":"Immunity"},{"issue":"3","key":"2025081210213591100_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet"},{"issue":"43","key":"2025081210213591100_bib26","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2025081210213591100_bib27","doi-asserted-by":"crossref","first-page":"e14336","DOI":"10.1111\/acel.14336","article-title":"Identification of AS1842856 as a novel small-molecule GSK3\u03b1\/\u03b2 inhibitor against tauopathy by accelerating GSK3\u03b1\/\u03b2 exocytosis","volume":"24","author":"He","year":"2025","journal-title":"Aging Cell"},{"issue":"D1","key":"2025081210213591100_bib28","doi-asserted-by":"crossref","first-page":"D1382","DOI":"10.1093\/nar\/gkab1047","article-title":"SwissBioisostere 2021: updated structural, bioactivity and physicochemical data delivered by a reshaped web interface [published correction appears in Nucleic Acids Res. 2022;50(5):2990]","volume":"50","author":"Cuozzo","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"2025081210213591100_bib29","doi-asserted-by":"crossref","first-page":"D1137","DOI":"10.1093\/nar\/gks1059","article-title":"SwissBioisostere: a database of molecular replacements for ligand design","volume":"41","author":"Wirth","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2025081210213591100_bib30","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.bmcl.2011.01.094","article-title":"Quinolizidinone carboxylic acid selective M1 allosteric modulators: SAR in the piperidine series","volume":"21","author":"Kuduk","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"issue":"D1","key":"2025081210213591100_bib31","doi-asserted-by":"crossref","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","author":"Gilson","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2025081210213591100_bib32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrd1415","article-title":"GSK3 inhibitors: development and therapeutic potential","volume":"3","author":"Cohen","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2025081210213591100_bib33","doi-asserted-by":"crossref","first-page":"40716","DOI":"10.1038\/srep40716","article-title":"Activation of Wnt\/\u03b2-catenin signalling via GSK3 inhibitors direct differentiation of human adipose stem cells into functional hepatocytes","volume":"7","author":"Huang","year":"2017","journal-title":"Sci Rep"},{"issue":"13","key":"2025081210213591100_bib34","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","article-title":"\u03b2-catenin is a target for the ubiquitin\u2013proteasome pathway","volume":"16","author":"Aberle","year":"1997","journal-title":"EMBO J"},{"issue":"1","key":"2025081210213591100_bib35","doi-asserted-by":"crossref","first-page":"a007898","DOI":"10.1101\/cshperspect.a007898","article-title":"The \u03b2-catenin destruction complex","volume":"5","author":"Stamos","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2025081210213591100_bib36","article-title":"Targeted engagement of \u03b2-catenin-Ikaros complexes in refractory B-cell malignancies","author":"Cosgun","year":"15  2023","journal-title":"bioRxiv"},{"issue":"1","key":"2025081210213591100_bib37","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1038\/s41467-022-32285-1","article-title":"TP53-dependent toxicity of CRISPR\/Cas9 cuts is differential across genomic loci and can confound genetic screening","volume":"13","author":"\u00c1lvarez","year":"2022","journal-title":"Nat Commun"},{"issue":"7","key":"2025081210213591100_bib38","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","article-title":"CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response","volume":"24","author":"Haapaniemi","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"2025081210213591100_bib39","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1038\/s41467-023-43991-9","article-title":"Single cell multi-omics reveal intra-cell-line heterogeneity across human cancer cell lines","volume":"14","author":"Zhu","year":"2023","journal-title":"Nat Commun"},{"issue":"4","key":"2025081210213591100_bib40","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ccell.2019.03.005","article-title":"\u03b3-Catenin-dependent signals maintain BCR-ABL1+ B cell acute lymphoblastic leukemia","volume":"35","author":"Luong-Gardiol","year":"2019","journal-title":"Cancer Cell"},{"issue":"2","key":"2025081210213591100_bib41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3892\/or.2020.7888","article-title":"Involvement of Blnk and Foxo1 in tumor suppression in BCR-ABL1-transformed pro-B cells","volume":"45","author":"Zhang","year":"2021","journal-title":"Oncol Rep"},{"issue":"23","key":"2025081210213591100_bib42","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1016\/j.molcel.2022.10.025","article-title":"PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and RNA polymerase pause release at select gene targets","volume":"82","author":"Zhang","year":"2022","journal-title":"Mol Cell"},{"issue":"22","key":"2025081210213591100_bib43","doi-asserted-by":"crossref","first-page":"16472","DOI":"10.3390\/ijms242216472","article-title":"Dependency of B-cell acute lymphoblastic leukemia and multiple myeloma cell lines on MEN1 extends beyond MEN1-KMT2A interaction","volume":"24","author":"Wolffhardt","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5725","key":"2025081210213591100_bib44","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1126\/science.1109083","article-title":"Functional interaction between \u00df-catenin and FOXO in oxidative stress signaling","volume":"308","author":"Essers","year":"2005","journal-title":"Science"},{"issue":"1","key":"2025081210213591100_bib45","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13046-019-1174-3","article-title":"FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt\/\u03b2-catenin signaling","volume":"38","author":"Ling","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"2025081210213591100_bib46","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1136\/gutjnl-2023-331854","article-title":"DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer","volume":"73","author":"Brichkina","year":"2024","journal-title":"Gut"},{"issue":"9","key":"2025081210213591100_bib47","first-page":"2464","article-title":"Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism","volume":"116","author":"Matsumoto","year":"2006","journal-title":"J Clin Invest"},{"issue":"8","key":"2025081210213591100_bib48","doi-asserted-by":"crossref","first-page":"119059","DOI":"10.1016\/j.bbamcr.2021.119059","article-title":"The role of GSK3 in metabolic pathway perturbations in cancer","volume":"1868","author":"Papadopoli","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"6","key":"2025081210213591100_bib49","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cmet.2019.02.012","article-title":"Phosphoproteomics reveals the GSK3-PDX1 axis as a key pathogenic signaling node in diabetic islets","volume":"29","author":"Sacco","year":"2019","journal-title":"Cell Metab"},{"issue":"5","key":"2025081210213591100_bib50","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.50.5.937","article-title":"Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression","volume":"50","author":"Lochhead","year":"2001","journal-title":"Diabetes"},{"issue":"7523","key":"2025081210213591100_bib51","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13633","article-title":"Diabetes recovery by age-dependent conversion of pancreatic \u03b4-cells into insulin producers","volume":"514","author":"Chera","year":"2014","journal-title":"Nature"},{"key":"2025081210213591100_bib52","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1038\/ncomms9372","article-title":"Inhibition of DYRK1A and GSK3B induces human \u03b2-cell proliferation","volume":"6","author":"Shen","year":"2015","journal-title":"Nat Commun"},{"issue":"18","key":"2025081210213591100_bib53","doi-asserted-by":"crossref","first-page":"8624","DOI":"10.7150\/thno.48561","article-title":"Angiotensin IV attenuates diabetic cardiomyopathy via suppressing FoxO1-induced excessive autophagy, apoptosis and fibrosis","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"2025081210213591100_bib54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/cvr\/cvy255","article-title":"Inhibition of GSK-3 to induce cardiomyocyte proliferation: a recipe for in situ cardiac regeneration","volume":"115","author":"Singh","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"24","key":"2025081210213591100_bib55","doi-asserted-by":"crossref","first-page":"e160767","DOI":"10.1172\/JCI160767","article-title":"A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas","volume":"132","author":"Jang","year":"2022","journal-title":"J Clin Invest"},{"issue":"2","key":"2025081210213591100_bib56","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cell.2018.02.048","article-title":"B-cell-specific diversion of glucose carbon utilization reveals a unique vulnerability in B cell malignancies","volume":"173","author":"Xiao","year":"2018","journal-title":"Cell"},{"issue":"4","key":"2025081210213591100_bib57","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm.4062","article-title":"PTEN opposes negative selection and enables oncogenic transformation of pre-B cells","volume":"22","author":"Shojaee","year":"2016","journal-title":"Nat Med"},{"issue":"1","key":"2025081210213591100_bib58","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12964-024-01732-5","article-title":"Ikaros sets the threshold for negative B-cell selection by regulation of the signaling strength of the AKT pathway","volume":"22","author":"Ehm","year":"2024","journal-title":"Cell Commun Signaling"},{"key":"2025081210213591100_bib59","doi-asserted-by":"crossref","first-page":"579673","DOI":"10.3389\/fonc.2020.579673","article-title":"Down-regulated FOXO1 in refractory\/relapse childhood B-cell acute lymphoblastic leukemia [published correction appears in Front Oncol. 2020:10:629875]","volume":"10","author":"Zheng","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"2025081210213591100_bib60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/pbc.24034","article-title":"Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia","volume":"59","author":"Morishita","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"39","key":"2025081210213591100_bib61","doi-asserted-by":"crossref","first-page":"27583","DOI":"10.1074\/jbc.274.39.27583","article-title":"SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity","volume":"274","author":"Cuevas","year":"1999","journal-title":"J Biol Chem"},{"issue":"5","key":"2025081210213591100_bib62","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1182\/bloodadvances.2019001008","article-title":"The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia [published correction appears in Blood Adv. 2020;4(7):1217]","volume":"4","author":"Brown","year":"2020","journal-title":"Blood Adv"},{"key":"2025081210213591100_bib63","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.2147\/OTT.S245578","article-title":"PIM3 promotes the proliferation and migration of acute myeloid leukemia cells","volume":"13","author":"Luo","year":"2020","journal-title":"Onco Targets Ther"},{"issue":"4","key":"2025081210213591100_bib64","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1158\/0008-5472.CAN-17-2644","article-title":"Targeting CDK6 and BCL2 exploits the \u201cMYB addiction\u201d of Ph+ acute lymphoblastic leukemia","volume":"78","author":"De Dominici","year":"2018","journal-title":"Cancer Res"},{"issue":"1","key":"2025081210213591100_bib65","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1038\/s41467-019-10993-5","article-title":"Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma","volume":"10","author":"Ning","year":"2019","journal-title":"Nat Commun"},{"key":"2025081210213591100_bib66","doi-asserted-by":"crossref","first-page":"110039","DOI":"10.1016\/j.radonc.2023.110039","article-title":"Targeting the survival kinase DYRK1B: a novel approach to overcome radiotherapy-related treatment resistance","volume":"190","author":"Beckers","year":"2024","journal-title":"Radiother Oncol"},{"issue":"1","key":"2025081210213591100_bib67","doi-asserted-by":"crossref","first-page":"68","DOI":"10.21037\/atm-20-3140","article-title":"A narrative review of central nervous system involvement in acute leukemias","volume":"9","author":"Deak","year":"2021","journal-title":"Ann Transl Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/14\/3441\/2402087\/blooda_adv-2024-015560-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/14\/3441\/2402087\/blooda_adv-2024-015560-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T15:16:06Z","timestamp":1755011766000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/14\/3441\/537804\/Beyond-FOXO1-AS1842856-inhibits-GSK3-to-enhance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":67,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,7,22]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024015560","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,22]]},"published":{"date-parts":[[2025,7,10]]}}}